Wal­greens will build out spe­cial­ty phar­ma­cy busi­ness, lean­ing in­to drug and ther­a­py ser­vices

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

Wal­greens said Thurs­day it’s get­ting in­to cell and gene ther­a­py phar­ma­cy ser­vices and bring­ing its spe­cial­ty phar­ma­cy un­der a new name as it nav­i­gates the fu­ture of its busi­ness.

In ad­di­tion to set­ting up a cell and gene ther­a­py fa­cil­i­ty, Wal­greens is tak­ing its ex­ist­ing spe­cial­ty phar­ma­cy-re­lat­ed busi­ness­es, like com­mu­ni­ty phar­ma­cies that are lo­cat­ed near or in­side a health sys­tem, and putting them all in­to one di­vi­sion: Wal­greens Spe­cial­ty Phar­ma­cy. Ide­al­ly, the re­brand­ed spe­cial­ty phar­ma­cy busi­ness can bet­ter work with en­ter­prise part­ners like health plans, phar­ma and providers as a com­peti­tor to PBM-owned spe­cial­ty phar­ma­cies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER